Infosys Profits Rise to Rs 2,886 Crore in Q1, Beats Estimates
IT major Infosys beat margin expectations in June quarter and retained its full year guidance on Friday sending its shares up by 4 per cent in early trade. The stock was the top gainer on the 50-share Nifty benchmark. (Track stock)
Infosys' consolidated sales in the June quarter grew to Rs 12,770 crore against estimates of Rs 12,817 crore, but profits were higher at Rs 2,886 crore beating estimates of Rs 2,677 crore on the back of better-than-expected rise in margins.
Infosys operating margins at 25 per cent were 250 basis points ahead of estimates. Analysts had estimated margins to drop on the back of salary hikes and rupee appreciation.
Dollar revenues grew to $2113 million, lower than estimates of $2142 million, but Infosys retained its FY15 revenue growth outlook at 7-9 per cent.
The June quarter is considered to be seasonally strong for outsourcers because most clients firm up their IT budgets by March after which new orders begin to flow.
Infosys, once the bellwether among Indian IT firms, has lagged the IT industry over the last few years. Analysts have blamed Infosys' underperformance on its weakness to win new deals or mine existing clients because of its misplaced focus on products, platforms and consulting business (dubbed Infosys 3.0) at the cost of large "bread and b.utter" outsourcing deals. This led to shrinking market share and declining profitability.
Infosys brought back its cofounder Narayana Murthy in 2013 and under him the outsourcer doubled revenue growth and increase margins by aggressive cost-cutting in 2013-14 fiscal. But analysts say the company needs a new strategy to win back its bellwether tag. The responsibility to rejuvenate Infosys has been handed over to Vishal Sikka, who will take over as the new CEO on August 1
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.